Kun Zhou
- Molecular Biology top 5%
- Cancer Research top 2%
- Oncology
- Pharmacology top 2%
- Immunology
- Topics
- Bioactive natural compounds (12 papers)Natural product bioactivities and synthesis (10 papers)Bone Metabolism and Diseases (7 papers)
- Partner nations
- ChinaSwitzerlandUnited States
In The Last Decade
Kun Zhou
60 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 1.3k
- Cancer Research 653
- Oncology 232
- Pharmacology 189
- Immunology 154
Countries citing papers authored by Kun Zhou
This map shows the geographic impact of Kun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Zhou more than expected).
Fields of papers citing papers by Kun Zhou
This network shows the impact of papers produced by Kun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Zhou. The network helps show where Kun Zhou may publish in the future.
Co-authorship network of co-authors of Kun Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Kun Zhou. A scholar is included among the top collaborators of Kun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Zhou. Kun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 14 | |
| 6 | 20 | |
| 7 | 10 | |
| 8 | 11 | |
| 9 | 29 | |
| 10 | Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesisbreakdown → | 738 |
| 11 | 42 | |
| 12 | Effect of iron on forms and concentration of cadmium and expression of Cd-tolerance-related genes in tomato. | 2 |
| 13 | Effects of pyroligneous acid on quantity of microorganism and enzyme activity in alkaline soil. | 3 |
| 14 | 30 | |
| 15 | 5 | |
| 16 | 14 | |
| 17 | 1 | |
| 18 | 24 | |
| 19 | Study on the Hepatotoxicity of Boswellic Acids and Boswellia Serrata | 0 |
| 20 | Experimental Study on Chronic Toxicity of Radix Rehmanniae in Rats by Oral Administration | 1 |
About Kun Zhou
Kun Zhou is a scholar working on Pharmacology, Geriatrics and Gerontology and Complementary and alternative medicine, having authored 64 papers that have together received 1.7k indexed citations. Recurring topics across this work include Bioactive natural compounds (12 papers), Natural product bioactivities and synthesis (10 papers) and Bone Metabolism and Diseases (7 papers). The work is most often cited by research in Cancer Research (653 citations), Pharmacology (189 citations) and Molecular Biology (1.3k citations). Kun Zhou has collaborated with scholars based in China, Switzerland and United States. Frequent co-authors include Jingbo Sun, Xiaolong Liu, Xiaoli Ren, Zhicheng Zeng, Feifei Wang, Yanqing Ding, Wenting Liao, Liang Li, Yuling Li and Jinlong Hu. Their work appears in journals such as Nature Communications, PLoS ONE and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.